HOXB4 inhibits cell growth in a dose-dependent manner and sensitizes cells towards extrinsic cues

Cell Cycle

Volumn 5, Issue 1, 2006, Pages 14-22

  Will, Elke ^a   Speidel, Daniel ^b   Wang, Zheng ^c   Ghiaur, Gabriel ^a   Rimek, Andreas ^b   Schiedlmeier, Bernhard ^c   Williams, David A ^a   Baum, Christopher ^a,c   Ostertag, Wolfram ^c   Klump, Hannes ^c  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b LEIBNIZ INSTITUTE FOR EXPERIMENTAL VIROLOGY   (Germany)

^c HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Apoptosis; c Myc; Fibroblasts; HOXB4; Rat 1; Transformation

Indexed keywords

HOMEODOMAIN PROTEIN; TRANSCRIPTION FACTOR HOXB4; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL ACTIVATION; CELL DIFFERENTIATION; CELL GROWTH; CELL STRAIN; CELL TRANSFORMATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; EMBRYO; FIBROBLAST; GROWTH INHIBITION; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; LEUKEMOGENESIS; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; STEM CELL;

ANIMALIA;

EID: 33645291810     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.5.1.2304     Document Type: Article

References (57)

1. Sauvageau G, Lansdorp PM, Eaves CJ, Hogge DE, Dragowska WH, Reid DS, Largman C, Lawrence HJ, Humphries RK. Differential expression of homeobox genes in functionally distinct CD34+ subpopulations of human bone marrow cells. Proc Natl Acad Sci USA 1994; 91:12223-7.
2. Lawrence HJ, Largman C. Homeobox genes in normal hematopoiesis and leukemia. Blood 1992; 80:2445-53.
3. Pineault N, Helgason CD, Lawrence HJ, Humphries RK. Differential expression of Hox, Meis1, and Pbx1 genes in primitive cells throughout murine hematopoietic ontogeny. Exp Hematol 2002; 30:49-57.
4. Krosl J, Austin P, Beslu N, Kroon E, Humphries RK, Sauvageau G. In vitro expansion of hematopoietic stem cells by recombinant TAT-HOXB4 protein. Nat Med 2003; 9:1428-32.
5. Antonchuk J, Sauvageau G, Humphries RK. HOXB4-induced expansion of adult hematopoietic stem cells ex vivo. Cell 2002; 109:39-45.
6. Amsellem S, Pflumio F, Bardinet D, Izac B, Charneau P, Romeo PH, Dubart-Kupperschmitt A, Fichelson S. Ex vivo expansion of human hematopoietic stem cells by direct delivery of the HOXB4 homeoprotein. Nat Med 2003; 9:1423-7.
7. Brun AC, Fan X, Bjornsson JM, Humphries RK, Karlsson S. Enforced adenoviral vector-mediated expression of HOXB4 in human umbilical cord blood CD34+ cells promotes myeloid differentiation but not proliferation. Mol Ther 2003; 8:618-28.
8. Milsom MD, Duxbury R, Gagen D, Humphries RK, Schmidt M, von-Kalle C, Fairbairn LJ. Overexpression of HOXB4 confers a myelo-erythroid differentiation delay in vitro. Leukemia 2005; 19:148-53.
9. Schiedlmeier B, Klump H, Will E, Arman-Kalcek G, Li Z, Wang Z, Rimek A, Friel J, Baum C, Ostertag W. High-level ectopic HOXB4 expression confers a profound in vivo competitive growth advantage on human cord blood CD34+ cells, but impairs lymphomyeloid differentiation. Blood 2003; 101:1759-68.
10. Pilat S, Carotta S, Schiedlmeier B, Kamino K, Mairhofer A, Will E, Modlich U, Steinlein P, Ostertag W, Baum C, Beug H, Klump H. HOXB4 enforces equivalent fates of ES-cell-derived and adult hematopoietic cells. Proc Natl Acad Sci USA 2005; 102:12101-6.
11. Pineault N, Abramovich C, Ohta H, Humphries RK. Differential and common leukemogenic potentials of multiple NUP98-Hox fusion proteins alone or with Meis1. Mol Cell Biol 2004; 24:1907-17.
12. Krosl J, Baban S, Krosl G, Rozenfeld S, Largman C, Sauvageau G. Cellular proliferation and transformation induced by HOXB4 and HOXB3 proteins involves cooperation with PBX1. Oncogene 1998; 16:3403-12.
13. Shin SI, Freedman VH, Risser R, Pollack R. Tumorigenicity of virus-transformed cells in nude mice is correlated specifically with anchorage independent growth in vitro. Proc Natl Acad Sci USA 1975; 72:4435-9.
14. Krosl J, Sauvageau G. AP-1 complex is effector of Hox-induced cellular proliferation and transformation. Oncogene 2000; 19:5134-41.
15. Chang CP, Brocchieri L, Shen WF, Largman C, Cleary ML. Pbx modulation of Hox home-odomain amino-terminal arms establishes different DNA-binding specificities across the Hox locus. Mol Cell Biol 1996; 16:1734-45.
16. Shen WF, Chang CP, Rozenfeld S, Sauvageau G, Humphries RK, Lu M, Lawrence HJ, Cleary ML, Largman C. Hox homeodomain proteins exhibit selective complex stabilities with Pbx and DNA. Nucleic Acids Res 1996; 24:898-906.
17. Phelan ML, Featherstone MS. Distinct HOX N-terminal arm residues are responsible for specificity of DNA recognition by HOX monomers and HOX.PBX heterodimers. J Biol Chem 1997; 272:8635-43.
18. Pan Q, Simpson RU. c-myc intron element-binding proteins are required for 1, 25- dihydroxyvitamin D3 regulation of c-myc during HL-60 cell differentiation and the involvement of HOXB4. J Biol Chem 1999; 274:8437-44.
19. Zhang Y, Morrone G, Zhang J, Chen X, Lu X, Ma L, Moore M, Zhou P. CUL-4A stimulates ubiquitylation and degradation of the HOXA9 homeodomain protein. Embo J 2003; 22:6057-67.
20. Driever W, Nusslein-Volhard C. The bicoid protein determines position in the Drosophila embryo in a concentration-dependent manner. Cell 1988; 54:95-104.
21. McGinnis W, Krumlauf R. Homeobox genes and axial patterning. Cell 1992; 68:283-302.
22. Huang AM, Rusch J, Levine M. An anteroposterior Dorsal gradient in the Drosophila embryo. Genes Dev 1997; 11:1963-73.
23. Klump H, Schiedlmeier B, Baum C. Control of self-renewal and differentiation of hematopoietic stem cells: HOXB4 on the threshold. Ann NY Acad Sci 2005; 1044:1-10.
24. Klump H, Schiedlmeier B, Vogt B, Ryan M, Ostertag W, Baum C. Retroviral vector-mediated expression of HoxB4 in hematopoietic cells using a novel coexpression strategy. Gene Ther 2001; 8:811-7.
25. Schwieger M, Lohler J, Friel J, Scheller M, Horak I, Stocking C. AML1-ETO inhibits maturation of multiple lymphohematopoietic lineages and induces myeloblast transformation in synergy with ICSBP deficiency. J Exp Med 2002; 196:1227-40.
26. Will E, Klump H, Heffner N, Schwieger M, Schiedlmeier B, Ostertag W, Baum C, Stocking C. Unmodified Cre recombinase crosses the membrane. Nucleic Acids Res 2002; 30:e59.
27. Fehse B, Richters A, Putimtseva-Scharf K, Klump H, Li X, Ostertag W, Zander AR, Baum C. CD34 splice variant: An attractive marker for selection of gene-modified cells. Molecular Therapy 2000; 1:448-56.
28. Schambach A, Wodrich H, Hildinger M, Bohne J, Krausslich HG, Baum C. Context dependence of different modules for posttranscriptional enhancement of gene expression from retroviral vectors. Mol Ther 2000; 2:435-45.
29. Cosset FL, Takeuchi Y, Battini JL, Weiss RA, Collins MK. High-titer packaging cells producing recombinant retroviruses resistant to human serum. J Virol 1995; 69:7430-6.
30. Wahlers A, Schwieger M, Li Z, Meier-Tackmann D, Lindemann C, Eckert HG, von Laer D, Baum C. Influence of multiplicity of infection and protein stability on retroviral vector-mediated gene expression in hematopoietic cells. Gene Ther 2001; 8:477-86.
31. Gould A, Morrison A, Sproat G, White RA, Krumlauf R. Positive cross-regulation and enhancer sharing: Two mechanisms for specifying overlapping Hox expression patterns. Genes Dev 1997; 11:900-13.
32. Ryan M, Donelly M, Lewis A, Mehrotra AP, Wilkie J, Gani D. A model for nonstoichiometric, cotranslational protein scission in eukaryotic ribosomes. Bioorganic Chemistry 1999; 27:55-79.
33. Sauvageau G, Thorsteinsdottir U, Eaves CJ, Lawrence HJ, Largman C, Lansdorp PM, Humphries RK. Overexpression of HOXB4 in hematopoietic cells causes the selective expansion of more primitive populations in vitro and in vivo. Genes Dev 1995; 9:1753-65.
34. Hildinger M, Eckert HG, Schilz AJ, John J, Ostertag W, Baum C. FMEV vectors: Both retroviral long terminal repeat and leader are important for high expression in transduced hematopoietic cells. Gene Ther 1998; 5:1575-9.
35. Baum C, Itoh K, Meyer J, Laker C, Ito Y, Ostertag W. The potent enhancer activity of the polycythemic strain of spleen focus- forming virus in hematopoietic cells is governed by a binding site for Sp1 in the upstream control region and by a unique enhancer core motif, creating an exclusive target for PEBP/CBF. J Virol 1997; 71:6323-31.
36. Donnelly ML, Luke G, Mehrotra A, Li X, Hughes LE, Gani D, Ryan MD. Analysis of the aphthovirus 2A/2B polyprotein 'cleavage' mechanism indicates not a proteolytic reaction, but a novel translational effect: A putative ribosomal 'skip'. J Gen Virol 2001; 82:1013-25.
37. Cormier P, Pyronnet S, Salaun P, Mulner-Lorillon O, Sonenberg N. Cap-dependent translation and control of the cell cycle. Prog Cell Cycle Res 2003; 5:469-75.
38. Holland EC, Sonenberg N, Pandolfi PP, Thomas G. Signaling control of mRNA translation in cancer pathogenesis. Oncogene 2004; 23:3138-44.
39. Satoh Y, Matsumura I, Tanaka H, Ezoe S, Sugahara H, Mizuki M, Shibayama H, Ishiko E, Ishiko J, Nakajima K, Kanakura Y. Roles for c-Myc in self-renewal of hematopoietic stem cells. J Biol Chem 2004; 279:24986-93.
40. Pan Q, Simpson RU. Antisense knockout of HOXB4 blocks 1,25-dihydroxyvitamin D3 inhibition of c-myc expression. J Endocrinol 2001; 169:153-9.
41. Mateyak MK, Obaya AJ, Adachi S, Sedivy JM. Phenotypes of c-Myc-deficient rat fibroblasts isolated by targeted homologous recombination. Cell Growth Differ 1997; 8:1039-48.
42. Shiio Y, Donohoe S, Yi EC, Goodlett DR, Aebersold R, Eisenman RN. Quantitative proteomic analysis of Myc oncoprotein function. Embo J 2002; 21:5088-96.
43. Maulbecker CC, Gruss P. The oncogenic potential of deregulated homeobox genes. Cell Growth Differ 1993; 4:431-41.
44. Morgan R, Nalliah A, Morsi El-Kadi AS. FLASH, a component of the FAS-CAPSASE8 apoptotic pathway, is directly regulated by Hoxb4 in the notochord. Dev Biol 2004; 265:105-12.
45. Lohmann I, McGinnis N, Bodmer M, McGinnis W. The Drosophila Hox gene deformed sculpts head morphology via direct regulation of the apoptosis activator reaper. Cell 2002; 110:457-66.
46. Trumpp A, Refaeli Y, Oskarsson T, Gasser S, Murphy M, Martin GR, Bishop JM. c-Myc regulates mammalian body size by controlling cell number but not cell size. Nature 2001; 414:768-73.
47. Thompson EB. The many roles of c-Myc in apoptosis. Annu Rev Physiol 1998; 60:575-600.
48. Mann RS, Affolter M. Hox proteins meet more partners. Curr Opin Genet Dev 1998; 8:423-9.
49. Jaffe L, Ryoo H, Mann R. A role for phosphorylation by casein kinase II in modulating Antennapedia activity in Drosophila. Genes Dev 1997; 11:1327-40.
50. Vijapurkar U, Fischbach N, Shen W, Brandts C, Stokoe D, Lawrence HJ, Largman C. Protein kinase C-mediated phosphorylation of the leukemia-associated HOXA9 protein impairs its DNA binding ability and induces myeloid differentiation. Mol Cell Biol 2004; 24:3827-37.
51. Carr A, Biggin MD. An in vivo UV crosslinking assay that detects DNA binding by sequence-specific transcription factors. Methods Mol Biol 1999; 119:497-508.
52. Shen WF, Krishnan K, Lawrence HJ, Largman C. The HOX homeodomain proteins block CBP histone acetyltransferase activity. Mol Cell Biol 2001; 21:7509-22.
53. Saleh M, Rambaldi I, Yang XJ, Featherstone MS. Cell signaling switches HOX-PBX complexes from repressors to activators of transcription mediated by histone deacetylases and histone acetyltransferases. Mol Cell Biol 2000; 20:8623-33.
54. Huang H, Rastegar M, Bodner C, Goh SL, Rambaldi I, Featherstone M. MEIS C termini harbor transcriptional activation domains that respond to cell signaling. J Biol Chem 2005; 280:10119-27.
55. Abate-Shen C. Deregulated homeobox gene expression in cancer: Cause or consequence? Nat Rev Cancer 2002; 2:777-85.
56. Baum C, Hegewisch-Becker S, Eckert HG, Stocking C, Ostertag W. Novel retroviral vectors for efficient expression of the multidrug resistance (mdr-1) gene in early hematopoietic cells. J Virol 1995; 69:7541-7.
57. Zufferey R, Donello JE, Trono D, Hope TJ. Woodchuck hepatitis virus posttranscriptional regulatory element enhances expression of transgenes delivered by retroviral vectors. J Virol 1999; 73:2886-92.